3,5-Dimethyl-1H-Pyrrole-2-Carbaldehyde

3,5-Dimethyl-1H-pyrrole-2-carbaldehyde is catalogued under CAS 2199-59-9 and supplied as a pale yellow crystalline solid with a characteristic pyrrolic odour. The molecular formula is C₇H₉NO, and the relative molecular mass is 123.15 g·mol⁻¹. Typical lot release specifications require an assay by capillary GC (FID detection, DB‑5 column, 30 m × 0.25 mm × 0.25 µm film) of ≥98.5 area‑%, a melting‑point endotherm maximum in the range 40–42 °C (DSC, 10 K·min⁻¹, nitrogen purge), and water content ≤0.3 % w/w by Karl Fischer coulometric titration according to ASTM E203-16. The material is soluble in methanol, acetone, dichloromethane, and tetrahydrofuran; solubility in water at 20 °C is below 2 g·L⁻¹. Long‑term stability data from sealed amber‑glass containers stored at 2–8 °C under argon confirm a re‑test interval of 12 months; warming of opened containers without inert headspace at ambient relative humidity promotes oxidation to 3,5‑dimethyl‑1H‑pyrrole‑2‑carboxylic acid, detectable as an impurity with a relative retention time of 1.15 by the same GC method.

What Distinguishes 3,5-Dimethyl Substitution from Unsubstituted Pyrrole-2-carbaldehyde in Aldol‑Type Condensations?

The electron‑donating methyl groups at positions 3 and 5 raise the π‑electron density of the pyrrole ring, which moderates the electrophilicity of the adjacent aldehyde carbon. This electronic perturbation manifests as an increase in the activation barrier for Schiff‑base formation with primary amines: in a head‑to‑head experiment using n‑butylamine in methanol at 25 °C, the half‑life for imine generation from 3,5‑dimethyl‑1H‑pyrrole‑2‑carbaldehyde was 2.3‑fold longer than that of pyrrole‑2‑carbaldehyde, as monitored by in‑line ReactIR™ 15 with a 6 mm diamond ATR probe. Steric shielding of the carbonyl by the flanking methyl groups further retards nucleophilic attack: the dihedral angle imposed on the attacking trajectory lowers the frequency factor in the Arrhenius expression, a factor that becomes kinetically dominant in polar aprotic media. In practical synthetic work this reduced reactivity is advantageous for one‑pot sequential transformations where premature condensation must be avoided, yet it requires extended reaction times when using weakly nucleophilic partners such as electron‑deficient anilines—a constraint documented in patent literature describing the synthesis of dipyrromethene ligands for lanthanide‑based luminescent probes. Directly downstream of raw‑material reception, the aldehyde is often dehydrated under dynamic vacuum to enable high‑yielding Knoevenagel condensations. A Hastelloy C-22 agitated filter‑dryer operating at 30 °C jacket temperature, with a nitrogen bleed of 0.5 L·min⁻¹, reduces the Karl Fischer value below 0.05 % w/w within 6 h. Failure to conduct this pre‑drying step leads to a pronounced drop in isolated yield of the meso‑phenyl‑dipyrromethane product, from a typical 78–82 % range to 41–53 % in pilot campaigns, because the water present hydrolyses the intermediate enamine and shifts the equilibrium back toward the starting materials. Residues of polar aprotic solvents that co‑crystallise with the product—most notably N,N‑dimethylformamide (DMF) retained at 0.15 % w/w or above—poison palladium catalysts used in a subsequent Suzuki coupling of the brominated dipyrromethane scaffold. X‑ray photoelectron spectroscopy of the deactivated Pd/C catalyst from such a batch revealed a 1.4 at.‑% nitrogen signal originating from adsorbed formamide decomposition products, confirming the poisoning pathway.

Table 1 – Comparative Physical and Reactivity Data for Selected Pyrrole-2-carbaldehyde Derivatives

Compound	Substituent Pattern	Melting Point (°C)	Observed Reactivity Ranking (Schiff-Base with n-butylamine)	CAS RN
1H-Pyrrole-2-carbaldehyde	None	Liquid (b.p. 217)	High (reference)	1003-29-8
3,5-Dimethyl-1H-pyrrole-2-carbaldehyde	3,5‑CH₃	40–42	Moderate	2199-59-9
2,4-Dimethyl-1H-pyrrole-3-carbaldehyde	2,4‑CH₃; formyl at C3	66–68	Low	2199-60-2
3,5-Diethyl-1H-pyrrole-2-carbaldehyde	3,5‑C₂H₅	31–33	Moderate‑Low	86454-33-3

When Aldehyde Moisture Uptake Compromises Porphyrin Yield in High‑Humidity Production Environments

Campaigns run in coastal manufacturing facilities routinely encounter ambient relative humidity above 60 %, which necessitates rigorous atmospheric exclusion from the moment of container opening. In one documented instance, a 50‑L glass‑lined reactor charged with aldehyde that had been exposed to plant air for 25 min during manual scooping delivered a final tetraphenylporphyrin yield of only 4.2 % after acid‑catalysed condensation with benzaldehyde, compared with the 22 % benchmark that is typical for this one‑pot Adler–Longo protocol. Karl Fischer analysis of the exposed solid showed water adsorption at 0.8 % w/w, and HPLC‑MS of the crude reaction mixture identified the amino‑alcohol arising from water addition to the aldehyde‑pyrrole condensation intermediate as the major side product. Mitigation involves purging a nitrogen‑flushed glovebag with 8–10 volume exchanges before decanting the solid into the reactor feed hopper. An alternative strategy, adopted from multi‑tonnage pyrrole chemistry, uses a continuous screw feeder blanketed with dry nitrogen and coupled to a loss‑in‑weight gravimetric control; the residual moisture level in the fed material is then monitored by an in‑situ NIR probe calibrated against primary Karl Fischer data, maintaining a process setpoint of ≤0.10 % w/w.

Pharmaceutical Intermediate Processing: cGMP and Supply Chain Documentation

When the aldehyde serves as a registered starting material for an active pharmaceutical ingredient under development, the supplier quality system must conform to ISO 9001:2015 and provide a full analytical dossier. Typical documentation includes a statement of GMP compliance in accordance with ICH Q7, a validated HPLC method for purity and related substances per ICH Q2(R1) guidelines, and a residual solvent profile analysed by headspace GC‑FID using USP <467> Procedure A. The aldehyde is frequently employed in the synthesis of kinase inhibitor intermediates that contain a 3,5‑dimethyl‑pyrrol‑2‑yl pharmacophore; one route converts it to the corresponding nitrile via oxime formation with hydroxylamine hydrochloride in dimethylacetamide, followed by acetic anhydride dehydration at 110 °C. Process development batches have demonstrated reproducibility at 15‑kg scale, with the oxime intermediate isolated in 94 % yield and the nitrile in 87 % yield, both after crystallisation from 2‑propanol/water. It is essential that the aldehyde lot be free of pyrrole polymerisation products that co‑eluate as a broad hump in the GC trace, because these oligomers persist through the nitrile formation and generate genotoxic impurities requiring dedicated purification by silica gel column chromatography, which adds 3–5 days to the campaign timeline. The production of agrochemical actives targeting invertebrate nicotinic acetylcholine receptors also draws on this building block. 3,5‑Dimethyl‑1H‑pyrrole‑2‑carbaldehyde is converted into 2‑cyano‑3,5‑dimethyl‑pyrrole, a key fragment of certain insecticidal oxadiazine compounds. Scale‑up batches for field‑trial quantities employ a tubular flow reactor for the dehydration step, operating at 120 °C with a 12‑min residence time, which supresses the formation of acetamide by‑products that are otherwise observed at 3–4 area‑% in batch mode.

An Unexpected Pyrrolic Rearrangement During Grignard Addition: Process Safety Note

Nucleophilic addition of organomagnesium reagents to the aldehyde group at the 2‑position can be accompanied by a ring‑opening side reaction if the local temperature exceeds 25 °C. Calorimetric data from an RC1e reaction calorimeter (Mettler Toledo) indicate an onset of exothermic activity at 28 °C, with a total specific heat release of −385 kJ·kg⁻¹ over a 30‑min period during the addition of MeMgBr (3.0 M in 2‑MeTHF) to a 0.5 M solution of the aldehyde at 0 °C. Adiabatic temperature rise calculations place the potential runaway temperature at 142 °C, well above the boiling point of the solvent and triggering a pressure hazard. The recommended safe operating envelope limits the jacket setpoint to −10 °C during the Grignard addition, with an automated feed‑forward temperature controller that interrupts dosing if the reaction mass temperature exceeds 10 °C. In‑line FTIR monitoring tracks the disappearance of the carbonyl stretch at 1665 cm⁻¹; once the signal reaches baseline, an additional 15‑min hold at −5 °C ensures complete conversion before the quenching sequence starts.

Table 2 – Critical Process Parameters and Quality Attributes for Large‑Scale Schiff‑Base Condensation with 4‑Fluoroaniline

Parameter	Setpoint / Range	Analytical Method	Specification Rationale
Aldehyde purity (GC)	≥99.0 area‑%	ASTM D6850-18 (modified)	Unidentified impurities cause colour bodies in final imine
Water content of aldehyde charge	≤0.10 % w/w	ASTM E203-16	Water hydrolyses imine, equilibrium yield loss
Reaction temperature	20–25 °C	Pt‑100 probe in reaction mass	Exotherm onset at 26 °C leads to by‑product formation
4‑Fluoroaniline addition rate	0.8–1.0 mol·h⁻¹	Coriolis mass flow meter	Maintain concentration of free amine low to avoid bis‑addition
Agitation speed	200–250 rpm	Tachometer (retrofit)	Ensure dispersion without vortexing in 100‑L reactor
Imine melting point	98–100 °C	DSC, 10 K·min⁻¹	Confirms identity and absence of methanol‑solvate polymorph

Material Incompatibilities and Long‑Term Storage Stability

The aldehyde is incompatible with strong reducing agents, in particular lithium aluminium hydride and sodium borohydride‑cerium trichloride combinations that reduce the aldehyde to 3,5‑dimethyl‑1H‑pyrrole‑2‑methanol even at −20 °C; such reductions should be performed with the aldehyde added to a pre‑cooled suspension of the reducing agent to avoid concentration spikes. Contact with even trace amounts of primary amines in the presence of carboxylic acid carriers—a condition that can occur when the aldehyde is stored in multi‑use containers previously holding amine salts—results in the formation of a Schiff‑base oligomer layer on the crystal surface, visible as a reddish discolouration that increases the impurity count by 0.3–0.7 area‑%. Storage under inert gas in amber borosilicate glass at 2–8 °C is mandatory; excursion to 25 °C for more than 48 h generates the corresponding carboxylic acid at a rate of 0.05 % per day under 1 atm air, as quantified by spiked calibration standards with a limit of quantitation of 0.01 % w/w. For laboratories operating in tropical climates without reliable cold storage, the freeze‑dried inclusion complex with β‑cyclodextrin (1:1 molar ratio) has been shown to suppress oxidation for up to 6 months when kept in sealed aluminium laminate pouches, although reconstitution in organic solvent must then account for the carrier mass, adding an extra gravimetric adjustment of ±1.2 % to the batch charging calculation. Suppliers offering the product under a Drug Master File provide a stability‑indicating GC method that resolves the acid impurity at RRT 1.18 and confirm that no new degradation products appear after 36 months of frozen storage at −20 °C, with a specification of ≤0.5 % total degradation.